Molloy E S, Morgan M P, Doherty G A, McDonnell B, O'Byrne J, Fitzgerald D J, McCarthy G M
Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Osteoarthritis Cartilage. 2009 May;17(5):686-92. doi: 10.1016/j.joca.2008.09.014. Epub 2008 Oct 17.
Basic calcium phosphate (BCP) crystals have been implicated in the pathogenesis of osteoarthritis (OA), in part because of their ability to upregulate cyclooxygenase and prostaglandin E(2) (PGE(2)) production. The aim of this work was to investigate the expression of terminal PGE(2) synthases and PGE(2) receptors (EP) in BCP crystal-stimulated fibroblasts.
Cultured fibroblasts were stimulated with BCP crystals in vitro. mRNA expression was measured by real-time polymerase chain reaction, and protein production by western blotting.
Basal expression of microsomal prostaglandin E(2) synthase 1 (mPGES1) in osteoarthritic synovial fibroblasts (OASF) was found to be 30-fold higher than in human foreskin fibroblasts (HFF). BCP crystals increased mPGES1 expression fourfold in HFF, but not in OASF. EP4 expression was downregulated twofold by BCP crystals in OASF, but not in HFF. Exogenous PGE(2) also downregulated EP4 expression; this effect was blocked by co-administration of L-161,982, a selective EP4 antagonist. While administration of exogenous PGE(2) significantly upregulated mPGES1 expression in OASF, mPGES1 expression was threefold higher in the OASF treated with BCP crystals and PGE(2) as compared with OASF treated with PGE(2) alone.
The differing effects of BCP crystals on mPGES1 expression in HFF and OASF may be explained by BCP crystal-induced EP4 downregulation in OASF, likely mediated via PGE(2). These data underline the complexity of the pathways regulating PGE(2) synthesis and suggest the existence of a compensatory mechanism whereby mPGES1 expression can be diminished, potentially reducing the stimulus for further PGE(2) production.
碱性磷酸钙(BCP)晶体与骨关节炎(OA)的发病机制有关,部分原因是其能够上调环氧化酶和前列腺素E2(PGE2)的产生。本研究旨在探讨BCP晶体刺激的成纤维细胞中末端PGE2合酶和PGE2受体(EP)的表达。
体外培养的成纤维细胞用BCP晶体刺激。通过实时聚合酶链反应测量mRNA表达,通过蛋白质印迹法测量蛋白质产生。
发现骨关节炎滑膜成纤维细胞(OASF)中微粒体前列腺素E2合酶1(mPGES1)的基础表达比人包皮成纤维细胞(HFF)高30倍。BCP晶体使HFF中的mPGES1表达增加四倍,但在OASF中未增加。BCP晶体使OASF中的EP4表达下调两倍,但在HFF中未下调。外源性PGE2也下调EP4表达;这种作用被选择性EP4拮抗剂L-161,982共同给药所阻断。虽然给予外源性PGE2显著上调了OASF中mPGES1的表达,但与单独用PGE2处理的OASF相比,用BCP晶体和PGE2处理的OASF中mPGES1的表达高3倍。
BCP晶体对HFF和OASF中mPGES1表达的不同影响可能是由于BCP晶体诱导的OASF中EP4下调,可能是通过PGE2介导的。这些数据强调了调节PGE2合成途径的复杂性,并提示存在一种补偿机制,通过该机制mPGES1表达可以减少,潜在地减少进一步产生PGE2的刺激。